View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

Bullish Developments Continue; Downgrading Communications Bullish developments continue to flood the market, leading us to believe we may be in the early stages of a broad-based advance. • Bullish Arguments Flooding the Market. Major global and US indexes (SPY, RSP, QQQ, EEM, EFA, EUFN, ACWI, Europe, Japan, etc.) are making bullish inflections. Serial laggards such as retail (XRT) and biotech (IBB, XBI) appear to be bottoming. Cyclical Sectors are breaking topside resistance (e.g., XLK, XLF,...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

Cautious outlook intact We continue expect additional consolidation, volatility, and potentially lower prices as the market attempts to stabilize. Important levels we are monitoring on the S&P 500 include support near 2,600 and resistance near 2,817 - which currently coincides with both the 100-day and 50-day moving averages. • Big picture trends. The growth (IUSG) vs. value (IUSV) uptrend is breaking down in favor of value -- shift exposure from growth to value. The large-cap (IVV) vs. smal...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

S&P 500 at new all-time highs with uptrend intact Risk-on. The S&P 500 has surpassed the January all-time high, staying above this level for over a week. What's more important is the 5-month uptrend remains intact and cyclical/risk-on areas are reasserting their leadership status. Think technology, discretionary, and biotech/medical devices - all current overweights. At the same time, defensive areas have petered out in terms of relative strength, exactly what we want to see in a healthy bull m...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion ETF Pathfinder: Actionable ETF research & Ideas

YTD S&P 500 trading range continues; Avoid broad international exposure Constructive but murky outlook for U.S. equities paints an overall mixed picture, making sector/group/stock selection critical. • Bull case: (1) advance-decline (A-D) lines and other breadth indicators (% of stocks above 50-, 200-day moving averages) are neutral to positive; (2) price and RS uptrends remain intact for risk-on segments, including Technology (XLK), biotech (XBI, IBB), and growth stocks (IUSG); and (3) the ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • We are upgrading Health Care to an overweight. XLV is breaking topside a bullish base and reversing a 9-month RS downtrend. • Biotechs are leadership and are breaking out of bullish consolidation. XBI and IBB are constructive and making positive inflections. • Energy remains a leadership Sector with many bullish bases that are still unexploited. We have highlighted a number of them in today's Vital Signs.

Thierry Huteau
  • Thierry Huteau

USD ETFs SCORING (equity-fixed income-currency-commodity)

​Page 1 : Front pagePage 2 : One Day - One chartpage 3-4 : ETFs (equity-fixed income-currency-commodities) ABSOLUTE SCORING & RANKING (sorted by Scoring)page 5 : T&T 60 ETFs sample page 6 : Scoring and Chart read mode - Disclaimer

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch